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Embryonic  and  induced  pluripotent  stem  cells  have the ability  to differentiate  into  any  somatic  cell  type,
and  thus  have  potential  to  treat  a number  of diseases  that  are  currently  incurable.  Application  of these
cells  for clinical  or industrial  uses  would  require  an  increase  in  production  to yield adequate  numbers  of
viable  cells.  However,  the  relatively  high  costs  of cytokines  and  growth  factors  required  for  maintenance
of  stem  cells  in  the  undifferentiated  state have  the  potential  to  limit translational  research.  Leukemia




naïve  states  for both  human  and  mouse  stem  cells.  In this  study,  we describe  a new  recombinant  human
LIF  (rhLIF)  using  a plant-based  (rice) expression  system.  We found  that  rice-derived  rhLIF  possessed  the
same  speciﬁc  activity  as  commercial  Escherichia  coli-derived  LIF and  was  capable  of supporting  mouse
embryonic  stem  cell  proliferation  in  the  undifferentiated  state  as evidenced  from  pluripotency  marker
level  analysis.  Retention  of the pluripotent  state was  found  to  be indistinguishable  between  rice-derived
rhLIF  and  other  recombinant  LIF  proteins  currently  on  the  market.
 201©
. Introduction
Because they grow and differentiate into many cell types, stem
ells have the potential to remedy diseases that arise from cell death
r dysfunction of speciﬁc cell populations. Thus, intense research
fforts have focused on the application of stem cells for the treat-
ent of diabetes, heart failure, and neurodegenerative disorders
Santos et al., 2011; Murry and Keller, 2008). Embryonic stem
ells (ESCs) derived from the inner cell mass of pre-implantation
mbryos (Friel et al., 2005) can be cultured and expanded in
 pluripotent state in the presence of speciﬁc growth factors.
eukemia inhibitory factor (LIF), a member of the IL-6 cytokine
amily, is a key regulator in the maintenance of stem cell pluripo-
ency (Burdon et al., 2002). LIF activates gp130/STAT3-dependent
ignaling, leading to increased transcription of stem cell state reg-
lators while simultaneously inhibiting differentiation (Burdon
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et al., 2002; Chambers and Tomlinson, 2009). Typically, LIF is sup-
plied to stem cell culture by co-culture with a feeder layer of
mitotically-inactivated mouse embryonic ﬁbroblasts (MEFs). How-
ever, problems arise with isolating stem cells due to inefﬁcient
separation of the two  cell types, and variations in stem cell pheno-
type have been noted due to the amount of secreted LIF based on the
preparation and condition of the MEFs, decreasing reproducibility
in co-culture systems.
Therefore,  mouse and human ESCs, and induced pluripotent
stem cells (iPSCs) require addition of exogenous LIF to maintain
pluripotency, often from a recombinant source (Williams et al.,
1988; Hirai et al., 2012). Currently marketed LIF proteins are esti-
mated to be a large part of the cost for mouse ESC culture (Feng
et al., 2009). Recently, plant hosts have emerged as powerful sys-
tems to express recombinant mammalian proteins in an efﬁcient
manner on a large scale (Zhang et al., 2010, 2012). We demonstrate
that rice-derive recombinant human LIF (rhLIF) displays similar
biochemical characteristics as commercially available rhLIF derived
from Escherichia coli. Further, we show that the rice-derived rhLIF is
capable of supporting mouse ESC (mESC) proliferation and pluripo-
Open access under CC BY-NC-ND license. tency with equal effectiveness as E. coli-derived LIF, demonstrating
that rice-derived rhLIF has signiﬁcantly lower endotoxin levels and
is an attractive alternative to LIF proteins currently on the market.
license. 
68 B.A. Youngblood et al. / Journal of Biotechnology 172 (2014) 67– 72
Table  1
Endotoxin levels in LIF from different commercial sources.a
Vendor Source Endotoxin speciﬁcation (EU/g)
Santa Cruz Biotechnology (catalog no. sc-4988) E. coli Not speciﬁed
Millipore (catalog no. LIF1010) E. coli <1
Life  Technologies (catalog no. PHC9481) E. coli <1
ORF  Genetics (catalog no. 01-A0880) Barley grain <0.05
Symansis (catalog no. 3014C) 293 cells Not speciﬁed














































wInVitria (catalog no. 777LIF048) Rice g
a Endotoxin levels were cited from product certiﬁcates of analysis from each ven
b Endotoxin level was measured in this study using the Pyrogene Endotoxin Dete
. Materials and methods
.1. Rice transformation and rhLIF expression
Microprojectile bombardment-mediated transformation of
mbryonic calli induced from the mature seeds of rice cultivar
engal (Oryza sativa,  subsp. Japonica) was performed as described
Zhang et al., 2010). The regenerated transgenic plants were des-
gnated as R0 transgenic events, and their progeny in successive
enerations were designated as R1, R2, etc. Eight R1 seeds from each
ransgenic event were randomly picked, and placed into eight wells
n one column of a 96 deep-well plate. Five hundred microliters
f PBS (pH 7.4) were dispensed into wells containing two 10 mm
iameter steel beads. Seed proteins were extracted by agitating
he plate with a Geno/Grinder 2000 (SPEX CertiPrep, Metuchen,
J) for 20 min  at 1300 strokes/min, followed by centrifugation with
 microplate centrifuge at 4000 rpm for 20 min. The supernatants
f protein extracts from eight of the same transgenic events were
ooled, and 3 L of pooled protein extracts were spotted on a
itrocellulose membrane. The dot blot was probed with mouse
nti-human LIF primary antibody (Cat. No. ab34427, Abcam, Cam-
ridge, MA)  as described (Zhang et al., 2010).
.2. Puriﬁcation of rhLIF
Procedures were performed at room temperature (22 ◦C) and
hemicals were from Sigma (St. Louis, MO)  or Amresco (Solon, OH)
nless otherwise stated.
Buffers – Buffer A: 58 mM acetic acid (pH 3.0). Buffer B: 25 mM
ris–Cl, 500 mM NaCl, pH 7.4. Buffer C: 25 mM Tris–Cl, 500 mM
aCl, 500 mM -d-Methyl Mannopyranoside, pH 7.4. Buffer D:
5 mM Sodium Phosphate, 150 mM NaCl, 0.02% Tween 20, pH 7.4,
repared using endotoxin-free water (G-Biosciences, St. Louis, MO).
Extraction – Total rice protein was extracted from de-husked
rown rice grain ﬂour expressing rhLIF (600 g) in 3.0 L of buffer A
y stirring on a magnetic stirrer for 1 h. Flour debris were removed
y the addition of 40 g of Diatomite ﬁltration aid (CelPure C300,
dvanced Minerals Co., Goleta, CA) and ﬁltration through a What-
an  #5 ﬁlter disk (100 mm)  in a Buchner funnel (fraction I).
Ammonium sulfate precipitation – Fraction I was chilled to 4 ◦C
nd precipitated with 1.09 kg of solid ammonium sulfate (65% satu-
ation, 0.398 g/mL) and centrifuged at 22,000 × g (Beckman JA-18)
t 4 ◦C for 20 min. Pellets were discarded and ammonium sulfate
oncentration in the supernatant was increased to 80% saturation
y addition of 0.097 g ammonium sulfate per mL  of supernatant
315 g total). This solution was centrifuged as above and the pellets
ere dissolved in buffer B (90 mL), and then subjected to diaﬁl-
ration through a 5 kDa molecular weight cutoff tangential ﬂow
ltration unit (Pellicon XL, Millipore) to produce fraction II.
Concanavalin A Chromatography – Fraction II was  loaded onto
 column containing 100 mL  of Concanavalin A Sepharose (GE
ealthcare, 3.5 × 15 cm)  equilibrated with Buffer B. The column
as washed with 3-column volumes of buffer B and eluted with<0.002
dicated.
Assay from Lonza (Walkersville, MD).
3-column volumes of buffer C at a ﬂow rate of 120 mL/h; 7-mL
fractions were collected. rhLIF eluted as the only peak and was
pooled at ¾ peak height. The pool was dialyzed into buffer D using
a 10 kDa molecular weight cutoff dialysis cassette (Thermo Fisher
Scientiﬁc, Rockford, IL), distributed in aliquots, and frozen in liq-
uid nitrogen for storage at −80 ◦C (fraction III). Bacterial endotoxin
contamination of this material was determined using a commercial
kit (Pyrogene Endotoxin Detection Assay, Lonza, Walkersville, MD).
2.3. M1  growth inhibition assay
LIF potency was  assessed by M1 leukemia cell differentiation
(Umemiya-Okada et al., 1992). Brieﬂy, 2-fold dilutions of rice-
derived rhLIF or E. coli-derived rhLIF (LIF1010, Millipore, Billerica,
MA)  were tested for M1  differentiation as evidenced by inhibition
of growth. Log-phase M1  cells (ATCC #TIB-192) were seeded at a
cell density of 7.0 × 104 in 1 mL  of growth media and incubated at
37 ◦C/6% CO2 for 120 h. An EC50, (the concentration of LIF to inhibit
growth of 50% of M1  cells) was derived using a 4-parameter model
to determine units per milligram active LIF (50 units was deﬁned
as 50% maximal response) (Umemiya-Okada et al., 1992).
2.4. Mouse ESC culture
Mouse C57BL/6 N Lex3.13 ESCs were maintained on 0.1%
gelatin-coated 6-well plates without feeder cells in Embryo
Max  DMEM (Millipore) supplemented with 15% ESC-qualiﬁed
fetal bovine serum (Hyclone/Thermo), 2 mM l-glutamine (Gibco),
0.1 mM -mercaptoethanol (Sigma), 0.1 mM MEM  non-essential
amino acid stock (Gibco), and 1000 U mouse leukemia inhibitory
factor (LIF, Millipore, ESG1106). ESCs were grown at 37 ◦C in a
humidiﬁed incubator in 5% CO2 and passaged every two days
(∼70–80% conﬂuency).
2.5. LIF comparison
Mouse ESCs were passaged as normal, then resuspended in
media supplemented with either 1000 U/mL E. coli-derived recom-
binant mouse LIF (Millipore, catalog no. ESG1106), 10 ng/mL
E. coli-derived recombinant human LIF (Millipore, LIF1010), or
10 ng/mL rice-derived rhLIF (InVitria, 777LIF048). Cells were grown
for 2, 4, 10, or 12 passages as indicated.
2.6. Quantitative RT-PCR
RNA was  extracted and genomic DNA eliminated from mESCs
using the Qiagen RNAeasy Kit. Complementary DNA was  prepared
from mouse ESC RNA by reverse transcription with Super Script
II RT (Invitrogen) as recommended by the manufacturer. 20 ng of
cDNA was  ampliﬁed in triplicates using 2× SYBR Green Master Mix
(Invitrogen). PCR was 95 ◦C for 10 min, 40 cycles of 95 ◦C for 15 s
followed by 55 ◦C for 1 min.
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Fig. 1. Rice-derived rhLIF is extensively glycosylated. (A) Diagram of the linear gene
expression cassette for hLIF protein expression. Indicated are the rice seed stor-
age protein glutelin 1 gene promoter (Gt1 promoter), the Gt1 signal peptide (SP),
the codon-optimized human leukemia inhibitory factor (hLIF), and the nopaline
synthase gene terminator of Agrobacterium tumefaciens (T-NOS). Mature LIF pro-
tein  sequence containing 180 amino acids (SwissProt accession number P15018)
was  back-translated with the codons optimized toward the codon-usage preference
of rice genes (http://www.kazusa.or.jp/codon) and synthesized by DNA 2.0 (Menlo
Park,  CA) and ligated into the expression vector pAPI405 containing rice seed stor-
age  protein glutelin 1 gene promoter (Gt1) including its signal peptide encoding
sequence (GenBank accession no. Y00687) and the nopaline synthase (nos) gene ter-
minator of A. tumefaciens. Plasmid pAPI146 expressing the hygromycin-resistance
gene under the control of a rice callus-speciﬁc beta-glucanase (Gns9) gene promoter
was  used as a selection marker (Zhang et al., 2010). (B) Five micrograms of puriﬁed
rice-derived rhLIF were electrophoresed on 4–20% SDS-PAGE (Life Technologies,
Carlsbad, CA), stained using colloidal Coomassie blue dye (SimplyBlueTM SafeStain,
Life Technologies, Carlsbad, CA), and destained in water. Lane 1, molecular weight
markers (BioRad laboratories, Hercules, CA); lane 2, puriﬁed rhLIF pool. Rice-derived
rhLIF runs as a smear between 19 and 30 kDa. (C) Comparison of rhLIF expressed in
human cells, rice, and E. coli. Proteins were electrophoresed as above, and blot-
ted  to nitrocellulose for Western blot detection with a mouse anti-LIF monoclonal
antibody. Image detection was using a Protein Simple Fluorochem Q imager (Sun-
nyvale, CA). Lane 1, molecular weight markers (BioRad Laboratories, Hercules, CA,















Fig. 2. Rice-derived rhLIF exhibits potent M1  differentiation activity and maintains
high mESC proliferation rate. (A) Mouse myeloid leukemia M1 cells were obtained
from ATCC (Catalog no. TIB-192, Manassas, VA) and were cultured in a fortiﬁed RPMI
1640 medium containing 10 mM HEPES (Life Technologies, Carlsbad, CA), 4.5 g/L glu-
cose, 1 mM sodium pyruvate, 1.5× RPMI vitamins and amino acids (Sigma Aldrich,
St.  Louis, MO) and 10% FBS (Thermo Fisher, Waltham, MA). Log-phase mouse M1
cells were plated in the presence of 0.004–40 ng/mL of rice-derived or E. coli-derived
recombinant human LIF as described in Methods. Both of the sourced recombinant
human LIF proteins exhibited potent inhibition of M1 proliferation as indicated by
the  EC50 (EC50 0.21 ± 0.02 ng/mL versus 0.34 ± 0.12 ng/mL for the rice-derived rhLIF
and  E. coli-derived rhLIF, respectively, P = 0.063). The rice-derived rhLIF exhibited
a  statistically insigniﬁcant enhanced potency of M1 growth inhibition (P = 0.06).
Data shown is a representative experiment of three independent experiments. Error
bars represent 1 standard deviation. (B and C) Embryonic stem cells were plated in
triplicate at 10,000 cells/well in the presence of E. coli-derived recombinant mouse
LIF, E. coli-derived recombinant human LIF, rice-derived recombinant human LIF,
or without LIF (−LIF). Growth was monitored by daily cell count and viability mea-
surements using a TC-10 automated cell counter (BioRad). (B) Cell proliferation of
mESCs cultured in rice-derived rhLIF was  indistinguishable from proliferation rates
in  cells cultured in E. coli-derived recombinant mouse and human LIF, with dou-
bling times of approximately 11 h. Cells cultured without LIF ceased proliferating at
5  days. (C) Viability of mESCs cultured in rice-derived rhLIF was  indistinguishable
from viability of cells cultured in E. coli-derived recombinant mouse and human LIF.ells  (Symansis, Timaru, New Zealand); lane 3, rice-derived recombinant human LIF
InVitria); lane 4, E. coli-derived recombinant human LIF (Abcam, Cambridge, MA).
0 ng of each puriﬁed protein was loaded in lanes 2–4.
. Results and discussion
.1. Genetic transformation, expression analysis, and puriﬁcation
f rhLIF
The expression cassette containing sequences encoding human
IF protein altered with codons biased toward favorable codon
sage in the rice proteome is presented in Fig. 1A. The rice cul-
ivar Bengal (Oryza sativa L. subsp. Japonica) was transformed
ith the LIF expression cassette (Fig. 1A) using microprojectile
ombardment-mediated transformation (Huang et al., 2001). To
dentify rhLIF expression, pooled seed protein from eight seeds of
ach fertile event were analyzed using immuno-dot blot with an
nti-human LIF antibody (Supplementary Fig. 1). Of 249 transgenic
70 B.A. Youngblood et al. / Journal of Biotechnology 172 (2014) 67– 72
Fig. 3. mESCs cultured in rice-derived rhLIF express alkaline phosphatase. mESCs
cultured for 12 passages in rice-derived rhLIF or E. coli-derived recombinant mouse






































Fig. 4. mESCs cultured in rice-derived rhLIF retain high expression of pluripo-
tency transcription factors. (A) and (B) mESCs cultured in rice-derived rhLIF
or  E. coli-derived recombinant mouse and human LIF were examined for the
expression of stem cell state regulators (Rps2, Pou5f1, Nanog,  and Zfp42) using
qRT-PCR at passages 4 (A) and 10 (B). mESCs cultured in LIF showed signiﬁ-
cantly higher expression of Pou5f1, Nanog, and Zfp42 than cells cultured without
LIF. A single asterisk (*) indicates P < 0.05; double asterisk (**) P < 0.01. Statistics
were calculated using One-way ANOVA followed by Dunnett’s test. Primers were
Pou5f1: 5′-GCCGTCTTTCCACCAGGCCC-3′ , 5′-TCGAGGATCCACCCAGCCCG-3′; Nanog:
5′-CCTGGTCCCCACAGTTTGCCT-3′ , 5′-GCAGGTCTTCAGAGGAAGGGCG-3′; and Zfp42:
5′-GCCTCACTGTGCTGCCTCCAAG-3′ , 5′-TTCCGCCCGGCCCTTTCTGG-3′ . The riboso-
mal  protein S2 (Rps2) served as a loading control and reference gene. Relative
expression was calculated using the Ct method (Livak and Schmittgen, 2001).
Ct was derived by normalizing the sample mean cycle threshold (Ct) with its
respective control Rps2 Ct. (C) Western blots with protein extracts (5 g) lysed with
RIPA buffer (50 mM Tris–HCl, pH 8.8, 150 mM NaCl, 0.1% SDS, 0.5% deoxycholate, 0.5%
NP-40) were loaded onto 10% SDS-polyacrylamide gels from cells grown in E. coli-
derived recombinant mouse LIF (lane 1), E. coli-derived recombinant human LIF (lane
2),  rice-derived recombinant human LIF (lane 3), or without LIF (lane 4). SDS-PAGEfactures instructions and immediately photographed. Cells were grown in E.
oli-derived recombinant mouse LIF (A), E. coli-derived recombinant human LIF (B),
ice-derived recombinant human LIF (C), or without LIF (D).
vents with R1 seeds, 22 were identiﬁed as positive, and two  (VB50-
0 and VB50-199) with high-level expression of rhLIF were selected
o proceed to the next generation.
Supplementary material related to this article can be found,
n the online version, at http://dx.doi.org/10.1016/j.jbiotec.
013.12.012.
Puriﬁcation of rhLIF by lectin afﬁnity chromatography took
dvantage of its extensive glycosylation (Fig. 1B and C and Sup-
lementary Fig. 2). Ammonium sulfate precipitation between 65
nd 80% saturation afforded a 4.6-fold puriﬁcation (assuming 100%
ecovery) and aided subsequent Concanavalin A-afﬁnity chro-
atography by eliminating trace rice glycoproteins. The puriﬁed
raction III rhLIF (Fig. 1B, lane 2) was determined to be >97% pure
y densitometry. Bacterial endotoxin contamination was <0.002
ndotoxin units/g  of puriﬁed rhLIF, which is less than those com-
only found on the market (Table 1).
Supplementary material related to this article can be found,
n the online version, at http://dx.doi.org/10.1016/j.jbiotec.
013.12.012.
.2. Rice-derived rhLIF activates M1  cell differentiation and
nduces mESC proliferation
We  compared the speciﬁc activity of rice-derived rhLIF to that
roduced in E. coli by a modiﬁed M1 cell differentiation assay that
uantitates inhibition of cell growth during LIF-dependent differ-
ntiation of mouse myeloid leukemia M1 cells into a macrophage
ineage (Ralph et al., 1983). The EC50 of rice-derived rhLIF
xhibited a slightly higher potency than E. coli-derived rhLIF
Fig. 2A). Rice-derived rhLIF was found to have a mean activity of
.4 ± 0.26 × 108 units/mg LIF while the E. coli-derived rhLIF showed
 speciﬁc activity of 1.54 ± 0.17 × 108 units/mg.
Growth rates and viability of mESCs were compared between
ultures treated with rice-derived rhLIF or E. coli-derived mouse
nd human LIF for up to 6 days. Cultures grown in the presence
f E. coli-derived mouse and human LIF and the rice-derived rhLIF
rew at nearly identical rates for at least 6 days with doubling times
f approximately 11 h (Fig. 2B). In addition, we observed no signif-
cant differences in viability using trypan blue exclusion of mESCs
ultured in the different LIF proteins (Fig. 2C). In the absence of
IF, cessation of growth was observed at day 5 (Fig. 2B) and wasgel was transferred to PVDF (Millipore) and probed using an anti-Oct3/4 monoclonal
antibody (Santa Cruz sc-5279) (top). Western blot using an anti--tubulin antibody
for  loading comparison (bottom).
accompanied by a reduced viability (Fig. 2C) and change in cellu-
lar morphology (Fig. 3D). These data indicate that the rice-derived
rhLIF maintains growth of mESCs to the same extent as currently
marketed mouse or human LIF proteins.
3.3. ESCs grown in the presence of rice-derived rhLIF retain
markers of pluripotency
ESCs grow in characteristic tight clusters while exhibiting alka-
line phosphatase staining (Wobus et al., 1984; Solter and Knowles,
B.A. Youngblood et al. / Journal of Bio
Fig. 5. Rice-derived rhLIF maintains expression of the cell surface pluripotency
marker SSEA-1 in mESCs. mESCs were cultured in E. coli-derived recombinant mouse
LIF (A), E. coli-derived recombinant human LIF (B), rice-derived recombinant human
LIF  (C), or without LIF (D). Approximately 2 × 106 cells were resuspended in FACS
buffer (1 × PBS, 10% FBS, 0.1% NaN3) and incubated on ice with either anti-SSEA1 cou-
pled to Alexa Fluor 647 (BD Biosciences #562277) or puriﬁed mouse IgM  isotype
control (Biolegend #4011618) for 45 min. Expression analysis was performed on a
BD  LSR II ﬂow cytometer. The Y-axes indicate number of cell events (no scale) and the




























Tanel is the percent of cells that were SSEA-1-positive, the coefﬁcient of variation
CV), and the mean ﬂuorescence intensity (Mean).
978). We  exploited this marker for comparing mESCs grown in
. coli-derived human or mouse recombinant LIF or rice-derived
hLIF. Alkaline phosphatase was easily detected in mESCs that were
ultured in E coli-derived recombinant mouse LIF (Fig. 3A), human
IF (Fig. 3B), or rice-derived rhLIF (Fig. 3C), and there were no appar-
nt differences in staining patterns. However, alkaline phosphatase
as far less detectable in mESCs grown without LIF (Fig. 3D), indi-
ating that these cells expressed less of this pluripotency marker.
We further examined the retention of pluripotency by deter-
ining mRNA expression levels of the transcription factors Pou5f1
Oct4), Nanog,  and Zfp42 (Rex1). As expected, mESCs cultured in
he presence of any of the LIF proteins showed signiﬁcantly higher
xpression of the stem cell state regulators than the –LIF con-
rol at passages 4 and 10 (Fig. 4A and B, Pou5f1, Nanog, Zfp42).
he rice-derived rhLIF was statistically indistinguishable from the
. coli-derived available recombinant human LIF in the expression
f mRNAs encoding the pluripotent state regulators, Pou5f1 and
anog for both passages 4 and 10. Oct4 protein levels were compa-
able between the cells cultured in the LIF proteins while the –LIF
ontrol had signiﬁcantly decreased expression (Fig. 4C).
The maintenance of the pluripotent state of mESCs cultured in
he presence of rice-derived LIF was further conﬁrmed by expres-
ion of the SSEA-1 surface antigen (Wobus et al., 1984) (Fig. 5C).
ithdrawal of LIF from the mESC cultures induced a signiﬁcantecrease in detectable SSEA-1 (Fig. 5D). Cells cultured in the
resence of either the E. coli-derived LIF (Fig. 5A and B) or the rice-
erived rhLIF (Fig. 5C) exhibited indistinguishable levels of SSEA-1.
hese results indicate that mESCs cultured with rice-derived rhLIFtechnology 172 (2014) 67– 72 71
exhibit robust growth, acceptable viability, and maintain pluripo-
tency markers.
4. Conclusions
We have expressed rhLIF produced in rice grain and demon-
strate an efﬁcient puriﬁcation scheme. Ride-derived rhLIF displays
bioequivalency to E. coli-derived rhLIF products currently on the
market for the culture of mouse stem cells. We believe that through
the high product yields, exceptional protein purity, and extremely
low endotoxin, this new rice-derived rhLIF protein could promote
stem cell propagation for clinical applications. Rice-derived rhLIF
is currently commercially available at http://www.InVitria.com.
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